970.10
2.49%
ICICI Securities Limited
Domestic sales comprise 31% of FY20 revenues with higher contribution from specialty (54% of domestic sales). However, despite having an established set-up, growth (FY16-20 CAGR of ~5%) has lagged the industry growth curve. The company is consciously focusing on this aspect with focus on overhauling of distribution channels (defocusing on trade...
Alembic Pharmaceuticals Ltd. is trading at high day volume of 323.4K.
More from Alembic Pharmaceuticals Ltd.
Recommended